It's the peptide longevity circles point to when they talk about telomeres and "resetting" aging — and the claims run far ahead of the human evidence. Here's what Epitalon actually is, what the science does and doesn't show, and exactly where it stands with the FDA in 2026.
Epitalon (also spelled "Epithalon" or "Epithalone") is a synthetic tetrapeptide — a short chain of four amino acids, Ala-Glu-Asp-Gly. It was developed in Russia at the St. Petersburg Institute of Bioregulation and Gerontology as a synthetic version of the active fragment of epithalamin, an extract of the pineal gland. In the lab it has been investigated mostly for telomerase activation, pineal/melatonin signaling, and broad "geroprotective" (anti-aging) effects. It is not a vitamin, a supplement, or an approved medication.
The honest headline: most of the evidence is preclinical or comes from older Russian research — cell cultures and animal models, with limited and largely uncontrolled human data. Claims that it "lengthens telomeres" and extends lifespan in people run well ahead of what rigorous trials have shown. That gap between loud marketing and thin human evidence is exactly what this page exists to close.
Epitalon is not an FDA-approved drug. Its status has moved recently, and the nuance matters:
Want the live picture? Our regulatory-status tracker shows exactly where Epitalon and other peptides stand right now, with the dated primary sources.
In cell and animal models, Epitalon has been reported to activate telomerase (hTERT) expression and extend the replicative capacity of cultured human fibroblasts, and Russian studies have explored pineal/melatonin regulation and antioxidant effects. Reviews describe a range of proposed geroprotective and neuroendocrine actions in those preclinical settings.
In humans, the picture is far thinner: the clinical literature is dominated by small, older, often uncontrolled Russian studies, and much of what circulates online is anecdote, not data. That doesn't mean it "doesn't work" — it means the evidence needed to say it does, safely, in people, largely isn't there yet. Treat confident anti-aging and telomere claims with skepticism.
Because Epitalon isn't FDA-approved, there is no official dosing. Commonly reported subcutaneous doses sit around 5–10 mg per day, typically run in short cycles of a couple of weeks. These are not approved or standardized doses — they reflect what clinics and the wider community commonly report using today, shared for education, not medical advice.
Epitalon typically ships as a freeze-dried (lyophilized) powder that must be reconstituted with bacteriostatic water before it's a liquid. The math — concentration and the volume to draw — trips a lot of people up, and a misplaced decimal is an easy way to dose 10× off. That's what our free tool is for:
Human safety data is limited. Reported effects in the literature are generally mild, but long-term safety in humans is simply not well established, and product quality varies enormously between sources. Because much of the supply is research-use-only and unregulated, purity, sterility, and accurate labeling are real concerns — which is why sourcing and testing matter as much as the molecule itself. Anything that purports to influence telomerase deserves particular caution given the open questions about long-term biology.
If you're considering Epitalon, the responsible path runs through a licensed provider who can weigh your situation, not a checkout page. Questions worth asking: Is there third-party testing and a certificate of analysis? What's the source and is it disclosed? What does the provider make of the current legal status? This isn't legal or medical advice — it's the baseline diligence any unapproved substance deserves.
"Epitalon" and "Epithalon" are the same synthetic tetrapeptide. "Epithalamin" is the older pineal-gland extract it was derived from — not the same thing as the synthetic peptide.
Telomerase activation has been reported in cell and animal studies, but human evidence is very limited and largely uncontrolled. Claims of telomere lengthening or life extension in people run ahead of the data.
No. It is not FDA-approved. It was removed from the Category 2 list in April 2026 but is not on the 503A bulks list, so it remains unlisted. Much of the supply is labeled research-use-only.
We don't sell peptides and we don't direct consumers to buy unapproved substances. If a licensed provider determines it's appropriate, sourcing and testing should be part of that conversation.
Educational information only. Not medical, legal, or regulatory advice, not a dosing, treatment, or efficacy claim, and not a recommendation to obtain or use any substance. Many peptides are not FDA-approved; some are labeled research-use-only ("not for human use"). Regulatory status changes frequently — verify independently and consult a licensed provider before any health decision. Published by Health Pro Distributors. © 2026.